383 related articles for article (PubMed ID: 19363214)
1. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.
Doe-Simkins M; Walley AY; Epstein A; Moyer P
Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of bystander-administered naloxone delivered by drone to opioid overdose victims.
Ornato JP; You AX; McDiarmid G; Keyser-Marcus L; Surrey A; Humble JR; Dukkipati S; Harkrader L; Davis SR; Moyer J; Tidwell D; Peberdy MA
Am J Emerg Med; 2020 Sep; 38(9):1787-1791. PubMed ID: 32739849
[TBL] [Abstract][Full Text] [Related]
3. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
Klimas J; Egan M; Tobin H; Coleman N; Bury G
BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
[TBL] [Abstract][Full Text] [Related]
4. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
[TBL] [Abstract][Full Text] [Related]
6. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
[TBL] [Abstract][Full Text] [Related]
8. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.
Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H
J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509
[TBL] [Abstract][Full Text] [Related]
9. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
[TBL] [Abstract][Full Text] [Related]
10. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
[TBL] [Abstract][Full Text] [Related]
11. Evidence-Based Guidelines for EMS Administration of Naloxone.
Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
[TBL] [Abstract][Full Text] [Related]
12. The implementation of a naloxone rescue program in university students.
Panther SG; Bray BS; White JR
J Am Pharm Assoc (2003); 2017; 57(2S):S107-S112.e2. PubMed ID: 28063773
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
Glaser A; Arakaki D; Chan GM; Hoffman RS
Med J Aust; 2005 Apr; 182(8):427; author reply 427, 429. PubMed ID: 15850442
[No Abstract] [Full Text] [Related]
14. Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management.
Dunn KE; Barrett FS; Bigelow GE
Addict Behav; 2018 Nov; 86():56-60. PubMed ID: 29625751
[TBL] [Abstract][Full Text] [Related]
15. Intranasal naloxone administration for treatment of opioid overdose.
Robinson A; Wermeling DP
Am J Health Syst Pharm; 2014 Dec; 71(24):2129-35. PubMed ID: 25465584
[TBL] [Abstract][Full Text] [Related]
16. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.
Katzman JG; Takeda MY; Greenberg N; Moya Balasch M; Alchbli A; Katzman WG; Salvador JG; Bhatt SR
JAMA Netw Open; 2020 Feb; 3(2):e200117. PubMed ID: 32101312
[TBL] [Abstract][Full Text] [Related]
17. Naloxone Administration by Untrained Community Members.
Eggleston W; Calleo V; Kim M; Wojcik S
Pharmacotherapy; 2020 Jan; 40(1):84-88. PubMed ID: 31782193
[TBL] [Abstract][Full Text] [Related]
18. Rapid widespread distribution of intranasal naloxone for overdose prevention.
Madah-Amiri D; Clausen T; Lobmaier P
Drug Alcohol Depend; 2017 Apr; 173():17-23. PubMed ID: 28182982
[TBL] [Abstract][Full Text] [Related]
19. Police Officers Can Safely and Effectively Administer Intranasal Naloxone.
Fisher R; O'Donnell D; Ray B; Rusyniak D
Prehosp Emerg Care; 2016; 20(6):675-680. PubMed ID: 27218446
[TBL] [Abstract][Full Text] [Related]
20. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
